» Articles » PMID: 10898980

Interaction of the TNF Homologues BLyS and APRIL with the TNF Receptor Homologues BCMA and TACI

Overview
Journal Curr Biol
Publisher Cell Press
Specialty Biology
Date 2000 Jul 19
PMID 10898980
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

BLyS (also called TALL-1, THANK, or BAFF) [1] [2] [3] [4] is a member of the tumor necrosis factor (TNF) gene family that stimulates proliferation and immunoglobulin production by B cells. BLyS interacts with the TNF receptor (TNFR) homologue TACI (transmembrane activator and CAML-interactor) [5], and treatment of mice with a TACI-Fc fusion protein abolishes germinal center formation after antigenic challenge [6]. Here we report a novel interaction between BLyS and another TNFR homologue, BCMA (B cell maturation antigen) [7] [8]. Further, the TNF homologue APRIL [9], a close relative of BLyS, also bound to BCMA and TACI. BLyS or APRIL activated nuclear factor-kappaB (NF-kappaB) through TACI and BCMA, and each ligand stimulated immunoglobulin M (IgM) production by peripheral blood B cells. These results define a dual ligand-receptor system that may play an important role in humoral immunity.

Citing Articles

The Antibody Drug Conjugate, Belantamab-Mafodotin, in the Treatment of Multiple Myeloma: A Comprehensive Review.

Almodovar Diaz A, Alouch S, Chawla Y, Gonsalves W Blood Lymphat Cancer. 2024; 14:71-87.

PMID: 39664714 PMC: 11631777. DOI: 10.2147/BLCTT.S490021.


BAFF promotes follicular helper T cell development and germinal center formation through BR3 signal.

Chen Y, Chen M, Liu Y, Li Q, Xue Y, Liu L JCI Insight. 2024; 9(21).

PMID: 39325665 PMC: 11601555. DOI: 10.1172/jci.insight.183400.


T cell Dissimilarities in B Cell Activating Factor-Deficient Versus B Cell Activating Factor Receptor 3-Deficient Systemic Lupus Erythematosus-Prone NZM 2328 Mice as Contributors to Their Divergent Clinical Outcomes.

Stohl W, Wu Y, Stohl M ACR Open Rheumatol. 2024; 6(11):756-768.

PMID: 39143363 PMC: 11557988. DOI: 10.1002/acr2.11712.


TACI and endogenous APRIL in B cell maturation.

Garcia-Carmona Y, Fribourg M, Sowa A, Cerutti A, Cunningham-Rundles C Clin Immunol. 2023; 253:109689.

PMID: 37422057 PMC: 10528899. DOI: 10.1016/j.clim.2023.109689.


Targeting BCMA in Multiple Myeloma: Advances in Antibody-Drug Conjugate Therapy.

Xing L, Liu Y, Liu J Cancers (Basel). 2023; 15(8).

PMID: 37190168 PMC: 10137208. DOI: 10.3390/cancers15082240.